• <td id="wjkko"></td>
    <code id="wjkko"><ol id="wjkko"></ol></code>
    <pre id="wjkko"><ruby id="wjkko"><menu id="wjkko"></menu></ruby></pre>
    <table id="wjkko"></table><track id="wjkko"><ruby id="wjkko"></ruby></track>

    <td id="wjkko"><ruby id="wjkko"></ruby></td>

          1. Biotechnology Product Manufacturing Industry Profile

            Report Page Length: 10-12
            Last Quarterly Update: 5/27/2020
            SIC Codes: 2836
            NAICS Codes: 325414
            Chapters Include:
            Industry Overview Trends & Challenges Industry Forecast
            Quarterly Industry Update Call Prep Questions Website & Media Links
            Business Challenges Financial Information Glossary & Acronyms
            View Full Sample Add To Cart

            Excerpt from Biotechnology Product Manufacturing Industry Profile

            Companies in this industry manufacture drugs, therapies, vaccines, and other products based on genetically manipulated compounds. Major companies include US-based Amgen, Biogen, Genentech (owned by Switzerland-based Roche), Gilead Sciences, and Monsanto, as well as CSL (Australia), Merck KGaA (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France).

            The global biotechnology industry generates total revenue of about $400 billion, according to Global Market Insights. Top regions for biotechnology include the US and Europe. Emerging markets include Australia, Canada, China, India, Singapore, Japan, and Brazil.

            The US biotechnology product manufacturing industry generates annual revenue of more than $100 billion. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. A separate industry report covers Pharmaceutical Manufacturing.

            COMPETITIVE LANDSCAPE

            Biotech firms face stiff competition from major pharmaceutical manufacturers and other companies seeking to be first with a new product or discovery. Development is often focused on high-demand, profitable markets such as cancer or rare disease treatment. Biopharmaceutical companies depend on gaining regulatory and insurance coverage approval for new treatments. They may also count on participation in government research or expedited approval programs.

            Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. Smaller companies often team up with larger manufacturers, financial backers, or marketing partners ...

             
            View Full Sample Add To Cart Return to the Industry Profile Menu

            Would you or your company benefit from having unlimited access to First Research's industry intelligence tools?

            Learn More About Subscription Options
             
            韩国电影-韩国三级-韩国r级电影-韩国理论片在线-天天影视网 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>